I agree, this could be big.
@gaucau ... they key word is "could"
Starpharma need to choose the right global partner and it could .... IMO if they have undertaken a production run, which Starpharma already claim to have done in previous announcements, then why hide who this was with - sign the deal already ? ... and make it a large global pharma deal instead of bits and pieces in each country with different groups because we can see how that is working out for Vivagel (NOT)
As I have mentioned previously, based on past performance I would also prefer the 'distribution pharma company' to handle all the regulatory body submissions, especially in the USA - just sayin'
GLTAH
P.S. ... I say again bring on the overdue DEP Docetaxel phase 2 mono results !
Ann: SPL7013 shows potent antiviral activity in RSV, page-20
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.0¢ | 9.6¢ | $5.703K | 58.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.41pm 11/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |